TrialAnnals of medicine2025

Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study.

Yessar Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.